Authorised representative (AR)
Zuellig Pharma Limited
裕利医药有限公司
Hong Kong MDACS·6 represented devices·3 applicants·Jun 12, 2015 – Jun 24, 2024
6
Total devices
3
Applicants
2015
First representation
2024
Most recent
AR overview
Bilingual authorised representative information and contact details
- Authorised representative (EN)
- Zuellig Pharma Limited
- Authorised representative (ZH)
- 裕利医药有限公司
- Phone
- 25799247
Timeline
- First representation
- Jun 12, 2015
- Most recent
- Jun 24, 2024
Risk class distribution
II
5
III
1
Applicant partnerships
Top manufacturers represented by this AR
Recent registrations
Latest 15 MDACS listings represented by Zuellig Pharma Limited
| Device | Risk class | Applicant | Registered |
|---|---|---|---|
| Tubes, Nasogastric, Feeding 管,鼻胃管,喂养 | II | Covidien llc Covidien Llc | Jun 24, 2024 |
| Drains, Sump 排水管,油底壳 | II | Covidien llc Covidien Llc | Jan 31, 2024 |
| Drains, Sump 排水管,油底壳 | II | Covidien llc Covidien Llc | Jan 31, 2024 |
| Drains, Thoracic 引流管,胸腔 | II | Covidien llc Covidien Llc | Nov 15, 2021 |
| Topical Solution/Cream/Gels, Injured Skin, Scar/Keloid Inhibition, Silicone Gel 外用溶液/乳膏/凝胶, 受伤皮肤, 瘢痕/瘢痕疙瘩抑制, 硅凝胶 | II | Stratpharma AG Stratpharma Ag | Mar 10, 2021 |
| Topical Solution/Creams, Eye Lubrication 外用溶液/乳膏,眼部润滑 | III | TUBILUX PHARMA S.p.A. TUBILUX PHARMA S.p.A. | Jun 12, 2015 |
About this profile
Zuellig Pharma Limited serves as the authorised representative for 6 medical devices in Hong Kong's MDACS framework. Analyse applicant partnerships, risk class exposure, and recent regulatory activity to understand their market footprint.